Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 10—October 2011

Research

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010

Laurence CalatayudComments to Author , Angie Lackenby, Arlene Reynolds, Jim McMenamin, Nick F. Phin, Maria Zambon, and Richard Pebody
Author affiliations: Health Protection Agency, London, UK (L. Calatayud, A. Lackenby, N.F. Phin, M.C. Zambon, R. Pebody); Health Protection Scotland, Glasgow, Scotland, UK (A. Reynolds, J. McMenamin)

Main Article

Table 2

Type of immunosuppression, presence of hematopoietic cell transplant, and outcomes for patients with oseltamivir-resistant pandemic (H1N1) 2009, England and Scotland, April 2009–April 30, 2010*

Type of immunosuppression No. with oseltamivir-resistant strains No. with hematopoietic cell transplant No. admitted to ICU No. deaths
Leukemia
Acute lymphocytic 2 1
Acute myeloid 3 2 1 1
Chronic lymphocytic 5 2 2 2
No precision
1



Lymphoma
Non-Hodgkin 2 1 1 1
Marginal zone 1
Mantle cell
2


1
Multiple myeloma 1 1 1
Aplastic anemia 1 1
Hematologic cancer with no precision 1 1
TRAPS 1
HIV 1 1
Total 21 8 5 7

*ICU, intensive care unit; TRAPS, tumor necrosis factor receptor–associated periodic syndrome.

*ICU, intensive care unit; TRAPS, tumor necrosis factor receptor–associated periodic syndrome.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO